26 May 2013
Keywords: new, results, sc, version, icatibant, germany, jerini
Article | 19 April 2004
Germany's Jerini has reported positive findings from a bioavailability study of its lead agent icatibant. The trial assessed the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 April 2004
26 April 2004
24 May 2013
© 2013 thepharmaletter.com